Meier H - Search Results

1

Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists.

Griebenow N, Bärfacker L, Meier H, Schneider D, Teusch N, Lustig K, Kast R, Kolkhof P. Griebenow N, et al. Among authors: meier h. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5891-4. doi: 10.1016/j.bmcl.2010.07.095. Epub 2010 Aug 1. Bioorg Med Chem Lett. 2010. PMID: 20728355

2

Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis.

Bauser M, Delapierre G, Hauswald M, Flessner T, D'Urso D, Hermann A, Beyreuther B, De Vry J, Spreyer P, Reissmüller E, Meier H. Bauser M, et al. Among authors: meier h. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1997-2000. doi: 10.1016/j.bmcl.2004.01.082. Bioorg Med Chem Lett. 2004. PMID: 15050645

3

Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution.

Fürstner C, Ackerstaff J, Meier H, Straub A, Mittendorf J, Schamberger J, Schäfer M, Börngen K, Jörißen H, Zubov D, Zimmermann K, Tersteegen A, Geiss V, Hartmann E, Albrecht-Küpper B, D'Orléans-Juste P, Lapointe C, Vincent L, Heitmeier S, Tinel H. Fürstner C, et al. Among authors: meier h. J Med Chem. 2024 Nov 14. doi: 10.1021/acs.jmedchem.4c01819. Online ahead of print. J Med Chem. 2024. PMID: 39541507

4

Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence.

Urbahns K, Yura T, Mogi M, Tajimi M, Fujishima H, Masuda T, Yoshida N, Moriwaki T, Lowinger TB, Meier H, Chan F, Madge D, Gupta JB. Urbahns K, et al. Among authors: meier h. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3354-7. doi: 10.1016/j.bmcl.2011.04.013. Epub 2011 Apr 9. Bioorg Med Chem Lett. 2011. PMID: 21531136

5

In silico ADMET traffic lights as a tool for the prioritization of HTS hits.

Lobell M, Hendrix M, Hinzen B, Keldenich J, Meier H, Schmeck C, Schohe-Loop R, Wunberg T, Hillisch A. Lobell M, et al. Among authors: meier h. ChemMedChem. 2006 Nov;1(11):1229-36. doi: 10.1002/cmdc.200600168. ChemMedChem. 2006. PMID: 16991174

6

Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits.

Wunberg T, Hendrix M, Hillisch A, Lobell M, Meier H, Schmeck C, Wild H, Hinzen B. Wunberg T, et al. Among authors: meier h. Drug Discov Today. 2006 Feb;11(3-4):175-80. doi: 10.1016/S1359-6446(05)03700-1. Drug Discov Today. 2006. PMID: 16533716 Review.

7

3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.

De Vry J, Denzer D, Reissmueller E, Eijckenboom M, Heil M, Meier H, Mauler F. De Vry J, et al. Among authors: meier h. J Pharmacol Exp Ther. 2004 Aug;310(2):620-32. doi: 10.1124/jpet.103.062836. Epub 2004 May 12. J Pharmacol Exp Ther. 2004. PMID: 15140913

8

An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer - against all odds?

Follmann M, Briem H, Steinmeyer A, Hillisch A, Schmitt MH, Haning H, Meier H. Follmann M, et al. Among authors: meier h. Drug Discov Today. 2019 Mar;24(3):668-672. doi: 10.1016/j.drudis.2018.12.003. Epub 2018 Dec 15. Drug Discov Today. 2019. PMID: 30562586 Free article. Review.

9

A lower X-gate in TASK channels traps inhibitors within the vestibule.

Rödström KEJ, Kiper AK, Zhang W, Rinné S, Pike ACW, Goldstein M, Conrad LJ, Delbeck M, Hahn MG, Meier H, Platzk M, Quigley A, Speedman D, Shrestha L, Mukhopadhyay SMM, Burgess-Brown NA, Tucker SJ, Müller T, Decher N, Carpenter EP. Rödström KEJ, et al. Among authors: meier h. Nature. 2020 Jun;582(7812):443-447. doi: 10.1038/s41586-020-2250-8. Epub 2020 Apr 29. Nature. 2020. PMID: 32499642

10

Historical redlining and clustering of present-day breast cancer factors.

Lima SM, Palermo TM, Aldstadt J, Tian L, Meier HCS, Louis HT Jr, Ochs-Balcom HM. Lima SM, et al. Among authors: meier hcs. Cancer Causes Control. 2025 Jan 4. doi: 10.1007/s10552-024-01950-9. Online ahead of print. Cancer Causes Control. 2025. PMID: 39755825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters